Results 71 to 80 of about 49,111 (247)

Feasibility, Safety, and Efficacy of Pulsed Field Ablation for Ventricular Arrhythmias: Insights From a Large Health System Registry in the United States

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Pulsed field ablation (PFA) is an emerging non‐thermal ablation modality with proven safety in atrial arrhythmia ablation. However, data on its performance for ventricular arrhythmias (VA) remain limited. Objective To evaluate the feasibility, safety, and efficacy of PFA for complex VA in a multicenter real‐world US registry ...
Narut Prasitlumkum   +22 more
wiley   +1 more source

1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW

open access: yesРациональная фармакотерапия в кардиологии, 2015
The clinical case of a rare proarrhythmic effect of antiarrhythmic drugs with a poor prognosis (medication-induced atrial flutter in a patient with "malignant" Kent’s bundle) is presented.
R. R. Mamatkazina   +4 more
doaj   +3 more sources

Impact of Ganglionated Plexus Ablation on Early Recurrence After Thoracoscopic Atrial Fibrillation Ablation: A Post Hoc Analysis of the AFACT Study

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Adjunctive ganglionated plexus (GP) ablation did not reduce early AF recurrence after thoracoscopic AF ablation but was associated with a later first recurrence. In the GP‐ablation group, early recurrence was associated with late recurrence; this exploratory finding is compatible with, but does not establish, a greater contribution of pre‐existing ...
Zhenyu Dong   +11 more
wiley   +1 more source

Antiarrhythmic agents [PDF]

open access: yes, 2010
Iako danas postoje i druge metode liječenja aritmija (kateterska ablacija, elektrostimulacija srca i sl.), antiaritmici su i dalje najčešće upotrebljavana terapija u prevenciji i liječenju nepravilnog ritma srca. Kako bi uspjeh liječenja aritmija bio što
Bilušić, Marinko, Bilušić, Antonija
core   +1 more source

Pharmacology of antiarrhythmic medications

open access: yes, 2018
antiarrhythmic drugs, side effects, interactions and factors to consider in choosing a particular drugáltalános orvosangolegységes ...
Samuel, Kalenebari Anthony
core  

Haemodynamic effects of class I antiarrhythmic agents.

open access: yes, 1985
peer reviewedIn order to choose the most appropriate antiarrhythmic agent, the basic haemodynamic characteristics of class I antiarrhythmic agents must be known.
Legrand, Victor, Collignon, P.
core   +1 more source

Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Clinical Outcomes of Pulmonary Vein Isolation Alone Versus Additional Lesion Sets in Paroxysmal Atrial Fibrillation ABSTRACT Background Pulmonary vein isolation (PVI) is the standard ablation strategy for paroxysmal atrial fibrillation (PAF). Despite guideline recommendations favoring PVI alone in PAF, some operators routinely perform extra pulmonary ...
Michel Abou Khalil   +17 more
wiley   +1 more source

Evaluation of teaching clinical pharmacology of antiarrhythmic drugs to first-year MBBS students through worksheet-based small-group discussion

open access: yesJournal of Pharmacy and Bioallied Sciences, 2017
Cardiac arrhythmias are a major cause of morbidity and mortality across the world. Learning the science behind the use of antiarrhythmic drugs is essential for all medical graduates. However, many antiarrhythmic drugs are available, and most of them have
Ameya A Hasamnis, Aditya Arya
doaj   +1 more source

Frequent Premature Ventricular Complexes and Catheter Ablation for Atrial Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Among 421 patients undergoing ablation of atrial fibrillation, frequent premature ventricular complexes (PVCs) > 1% were present in a significant proportion of patients at baseline. The PVC burden did not increase significantly in the post‐AF ablation period and was not associated with a higher rate of recurrent AF.
Abdulmohsen Alshakhs   +9 more
wiley   +1 more source

Flecainide‐Induced Interstitial Lung Disease: A Case Report and Review of the Literature

open access: yesClinical Case Reports
This case describes a rare adverse effect in which the subject developed interstitial lung disease after initiating a class IC antiarrhythmic, flecainide.
Elizabeth Jenkins   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy